Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients

被引:34
|
作者
Kotikoski, H
Moilanen, E
Vapaatalo, H
Aine, E
机构
[1] Tampere Univ Hosp, Dept Ophthalmol, FIN-33521 Tampere, Finland
[2] Univ Helsinki, Inst Biomed, Helsinki, Finland
[3] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2002年 / 80卷 / 02期
关键词
glaucoma; nitric oxide; aqueous humour; serum; pseudoexfoliation; blood pressure;
D O I
10.1034/j.1600-0420.2002.800214.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study the role of the L-arginine-nitric oxide (NO) pathway in aqueous humour dynamics by measuring nitrate, nitrite and cyclic (cGMP) levels in guanosine 3',5'-monophosphate the aqueous humour of glaucomatous and non-glaucomatous cataract patients. Methods: The study involved 38 glaucoma patients undergoing unilateral cataract surgery in the glaucomatous eye and 38 cataract control patients matched for sex, age, smoking habits and organic nitrate medication. All subjects underwent ophthalmic examination, and blood pressure was measured preoperatively. Nitrite, nitrate and cGMP levels were measured in aqueous humour and serum. Results: The NOx (nitrite + nitrate), nitrite and cGMP concentrations in the aqueous humour were slightly higher in the glaucoma patients than in the control patients, but the differences did not reach statistical significance. The levels of cGMP in serum were higher in the glaucoma patients (P = 0.053). The subgroup of glaucoma patients with pseudoexfoliation had lower NOx and nitrite values in the aqueous humour (P = 0.046 and P = 0.345, respectively) than the matched controls, while cGMP levels were higher (P = 0.043). Levels of NOx and nitrite in the aqueous humour were higher in patients using oral nitroglycerin (P = 0.062 and P = 0.042, respectively) than in patients without this medication. Blood pressure was higher in the glaucoma patients, with a mean of 165/89 mmHg as compared to 153/81 mmHg in the controls (P-values 0.071/0.008). Conclusions: No differences in NO metabolites were found between glaucoma and control patients. However, any real changes may have been disguised by optimal medication of glaucoma. Low NOx and high cGMP levels in the aqueous humour of pseudoexfoliation patients warrant further evaluation in a larger study.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [31] In primary aldosteronism hypertensive patients endothelial dysfunction is caused by an impairment in the L-arginine-nitric oxide pathway
    Sudano, I
    Virdis, A
    Ghiadoni, L
    Cardinal, H
    Taddei, S
    Salvetti, A
    CIRCULATION, 2000, 102 (18) : 179 - 179
  • [32] L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia
    Pimentel, Adriana M. L.
    Pereira, Natalia R.
    Costa, Cristiane A.
    Mann, Giovanni E.
    Cordeiro, Viviane S. C.
    de Moura, Roberto S.
    Brunini, Tatiana M. C.
    Mendes-Ribeiro, Antonio Claudio
    Resende, Angela C.
    HYPERTENSION RESEARCH, 2013, 36 (09) : 783 - 788
  • [33] L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia
    Adriana M L Pimentel
    Natália R Pereira
    Cristiane A Costa
    Giovanni E Mann
    Viviane S C Cordeiro
    Roberto S de Moura
    Tatiana M C Brunini
    Antônio Cláudio Mendes-Ribeiro
    Ângela C Resende
    Hypertension Research, 2013, 36 : 783 - 788
  • [34] Effects of Chronic Renal Failure on L-arginine-Nitric Oxide Pathway and Arginase in Erythrocytes
    Moss, Monique B.
    Siqueira, Mariana A. S.
    Martins, Marcela A.
    Pereira, Natalia R.
    Santos, Sergio F. F.
    Mendes Ribeiro, Antonio Claudio
    Brunini, Tatiana M. C.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 : S117 - S117
  • [35] Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
    Tang, Haiyang
    Vanderpool, Rebecca R.
    Wang, Jian
    Yuan, Jason X. -J.
    PULMONARY CIRCULATION, 2017, 7 (03) : 569 - 571
  • [36] THE L-ARGININE-NITRIC OXIDE PATHWAY IS THE MAJOR SOURCE OF PLASMA NITRITE IN FASTED HUMANS
    RHODES, PM
    LEONE, AM
    FRANCIS, PL
    STRUTHERS, AD
    MONCADA, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) : 590 - 596
  • [37] Possible involvement of l-arginine-nitric oxide pathway in the antidepressant activity of Auraptene in mice
    Amini-Khoei, Hossein
    Boroujeni, Shakiba Nasiri
    Maghsoudi, Forough
    Rahimi-Madiseh, Mohammad
    Bijad, Elham
    Moradi, Mohammadtaghi
    Lorigooini, Zahra
    BEHAVIORAL AND BRAIN FUNCTIONS, 2022, 18 (01)
  • [38] Say NO to Obesity-Related Hypertension Role of the L-Arginine-Nitric Oxide Pathway
    Rajapakse, Niwanthi W.
    Head, Geoffrey A.
    Kaye, David M.
    HYPERTENSION, 2016, 67 (05) : 813 - 819
  • [39] Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment
    Rajapakse, Niwanthi W.
    Nanayakkara, Shane
    Kaye, David M.
    PHARMACOLOGY & THERAPEUTICS, 2015, 154 : 1 - 12
  • [40] Impaired L-arginine-nitric oxide pathway contributes to he pathogenesis of resistant hypertension
    Rajapakse, Niwanthi W.
    Giam, Beverly
    Kuruppu, Sanjaya
    Head, Geoffrey A.
    Kaye, David M.
    CLINICAL SCIENCE, 2019, 133 (20) : 2061 - 2067